Nyxoah said it has won the CE Mark for its novel hypoglossal nerve stimulation therapy for treating obstructive sleep apnea (OSA).
The Genio system is a battery-free, leadless and minimally invasive neurostimulator designed to deliver bilateral hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea patients who have failed conventional continuous positive airway pressure (CPAP) therapy.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Nyxoah sleep apnea neuro-stim therapy gains CE Mark appeared first on MassDevice.
from MassDevice https://ift.tt/2UKW5bC
Cap comentari:
Publica un comentari a l'entrada